<DOC>
	<DOCNO>NCT01123980</DOCNO>
	<brief_summary>This trial conduct Asia . The aim clinical trial investigate blood sugar lower effect biphasic insulin aspart 30 daily compare insulin glargine daily combination metformin glimepiride Chinese Japanese subject type 2 diabetes never receive insulin . The trial conduct phase 4 trial China phase 3 Japan .</brief_summary>
	<brief_title>Comparison Blood Sugar Lowering Effect Biphasic Insulin Aspart 30 Insulin Glargine Both Combined With Metformin Glimepiride Chinese Japanese Subjects With Type 2 Diabetes New Insulin Treatment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 2 diabetes treat maximum three different type oral antidiabetic drug ( OADs ) ( include traditional Chinese medicine contains active ingredient know OADs ) 6 month Unchanged total daily dose least 1500 mg ( Chinese patient ) 500 mg ( Japanese patient ) metformin last two month Unchanged total daily dose least half maximum recommend total daily dose insulin secretagogue last two month Insulin naive HbA1c 7.0 % 10.0 % FPG ( fast plasma glucose ) equal 6.1 mmol/L ( 110mg/dL ) Body Mass Index ( BMI ) 40.0 kg/m^2 Treatment thiazolidinedione ( TZD ) GLP1 ( glucagon like peptide1 ) receptor antagonist last 3 month Visit 1 trial Any disease condition Investigator feel would interfere trial Any contraindication metformin glimepiride ( accord local labelling )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>